Barinthus Biotherapeutics plc. (BRNS) › Shareholders' EquityBarinthus Biotherapeutics plc. (BRNS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$22.08M2020: -$36.91M2021: $252.56M2022: $243.20M2023: $187.00M2024: $130.13M2025: $74.29M$74.29M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$74.29M-42.9%2024$130.13M-30.4%2023$187.00M-23.1%2022$243.20M-3.7%2021$252.56M+784.2%2020-$36.91M-67.2%2019-$22.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share